GB201712159D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB201712159D0
GB201712159D0 GBGB1712159.1A GB201712159A GB201712159D0 GB 201712159 D0 GB201712159 D0 GB 201712159D0 GB 201712159 A GB201712159 A GB 201712159A GB 201712159 D0 GB201712159 D0 GB 201712159D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1712159.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mexichem Fluor SA de CV
Original Assignee
Mexichem Fluor SA de CV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mexichem Fluor SA de CV filed Critical Mexichem Fluor SA de CV
Priority to GBGB1712159.1A priority Critical patent/GB201712159D0/en
Publication of GB201712159D0 publication Critical patent/GB201712159D0/en
Priority to PCT/GB2018/052109 priority patent/WO2019021005A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
GBGB1712159.1A 2017-07-28 2017-07-28 Pharmaceutical composition Ceased GB201712159D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1712159.1A GB201712159D0 (en) 2017-07-28 2017-07-28 Pharmaceutical composition
PCT/GB2018/052109 WO2019021005A1 (en) 2017-07-28 2018-07-26 Pharmaceutical composition comprising a cannabinoid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1712159.1A GB201712159D0 (en) 2017-07-28 2017-07-28 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB201712159D0 true GB201712159D0 (en) 2017-09-13

Family

ID=59778882

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1712159.1A Ceased GB201712159D0 (en) 2017-07-28 2017-07-28 Pharmaceutical composition

Country Status (2)

Country Link
GB (1) GB201712159D0 (en)
WO (1) WO2019021005A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2584686A (en) * 2019-06-11 2020-12-16 Mexichem Fluor Sa De Cv Methods
GB2586477A (en) * 2019-08-20 2021-02-24 Mexichem Fluor Sa De Cv Composition and method
GB2588087A (en) * 2019-09-27 2021-04-21 Senzer Ltd Inhalable cannabinoid compositions and uses
CN114515280B (en) * 2020-11-18 2023-08-11 云南汉盟制药有限公司 Pharmaceutical composition and application thereof
WO2023283592A1 (en) * 2021-07-08 2023-01-12 484 Science Corp. Formulations for the treatment of respiratory disorders
WO2023172210A1 (en) * 2022-03-08 2023-09-14 Prince Of Songkla University Cannabidiol metered dose inhalers for protection of covid antigen and other allergens
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006091922A1 (en) * 2005-02-25 2006-08-31 Unimed Pharmaceuticals, Inc. Dronabinol compositions and methods of using same
ES2441963T3 (en) * 2007-10-05 2014-02-07 Sti Pharmaceuticals Ltd. Pharmaceutical composition
GB201108039D0 (en) * 2011-05-13 2011-06-29 Mexichem Amanco Holding Sa Compositions
GB2524469A (en) * 2014-02-14 2015-09-30 Kind Consumer Ltd A cannabinoid inhaler and composition therefor

Also Published As

Publication number Publication date
WO2019021005A1 (en) 2019-01-31

Similar Documents

Publication Publication Date Title
IL265360B (en) Pharmaceutical composition
IL271657A (en) Pharmaceutical compositions
IL269061A (en) Pharmaceutical composition comprising selexipag
IL271986A (en) Pharmaceutical composition
IL265260B (en) Pharmaceutical composition
IL262654A (en) Pharmaceutical composition
IL265349A (en) Pharmaceutical composition
GB201712159D0 (en) Pharmaceutical composition
GB201705303D0 (en) Pharmaceutical compositions
SG11202001179YA (en) Pharmaceutical compositions
IL263040A (en) Pharmaceutical composition comprising eteplirsen
GB201719447D0 (en) Pharmaceutical composition
IL272419A (en) Pharmaceutical composition
GB201705305D0 (en) Pharmaceutical compositions
PL3454838T3 (en) Pharmaceutical composition
GB201705304D0 (en) Pharmaceutical compositions
GB201705306D0 (en) Pharmaceutical compositions
GB201615917D0 (en) Pharmaceutical composition
EP3727485C0 (en) Pharmaceutical composition
GB201615914D0 (en) Pharmaceutical composition
GB201615910D0 (en) Pharmaceutical composition
IL271513A (en) Novel pharmaceutical composition
IL272044A (en) Pharmaceutical compositions
IL265436B (en) Pharmaceutical composition
PL3424500T3 (en) Pharmaceutical composition comprising famitinib

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)